Wockhardt, headquartered in Mumbai, India, is a truly global pharmaceutical organisation, which is representing our nation on global medicinal platform.
It provides affordable, effective, high-quality medicines for a healthier, smarter, livelier world. It is India’s leading research-based, Innovation driven healthcare enterprise.
With operational presence in the fields as diverse as Pharmaceuticals, Biotechnology, Nano-medical ingredients and a chain of advanced Super Speciality Hospitals, Wockhardt is a true Indian Multi-National Company. It has a remarkable multi-ethnic workforce of 8600 Wockhardt Associates and Experts from 21 different countries globally. It was ranked as one of the most good organiisation to work for in a Human Resource Effectiveness Survey. To mention some of its world class infrastructure; It has 3 research centres and 12 manufacturing plants, with diverse range of business that includes Active Pharmaceutical Ingredients (APIs), the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations and Vaccines. Wockhardt was established by Habil Khorakiwala in the first half of 1960s.Later in the year of 1959 his father Fakhruddin acquired famous Worli Chemical Works . Wockhardt works with global partners to in-license biochemical products in India and out-license products into other targeted regions by capitalising on these collaborative strengths to capture and penetrate new markets.
Their most renowned brands are Aceroc, Ace Proxyvon, Biovac-B, Brozedex, Cavidin INH etc.